Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Myriad (Germany)
h-index: 51
Total citations: 16,023
Total papers: 275
Homepage:
https://www.myriad.com/
Recent papers from Myriad (Germany)
Maqasid Al-Shari’ah as a Governing Framework for Sustainable Development Governance
International Journal of Academic Research in Accounting Finance and Management Sciences · 2026
Evidence for resource transfer via common endophyte networks
Scientific Reports · 2026
Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer
Clinical Genitourinary Cancer · 2026
Guidelines for the management of acute porphyria: recommendations from the International Porphyria Network.
2026
Designing Granular Consent Tools for Sensitive Health Data: Challenges, User Needs, and Stakeholder Guidance
Applied Clinical Informatics · 2026
APOL1 Genetic Testing and Counseling Does Not Reduce Living Kidney Donors’ Willingness to Donate: A Hybrid Type 2 Non-Randomized Controlled Trial
Clinical Journal of the American Society of Nephrology · 2026
Abstract CT172: A phase II trial of adjuvant PD-1 blockade with endocrine therapy in hormone receptor positive inflammatory breast cancer: Circulating biomarkers and molecular correlates of clinical outcomes
Cancer Research · 2026
Abstract CT171: Early findings from MONITOR-Breast: ctDNA dynamics during neoadjuvant therapy using an ultrasensitive MRD assay
Cancer Research · 2026
Outcomes and Management of Pregnancies Screening Positive for Microdeletions 22q11.2, 15q11.2, 1p36, 4p, or 5p: A Retrospective Cohort Study
The Application of Clinical Genetics · 2026
Abstract 7368: Dynamic molecular and immune characterization for personalized treatment in locally advanced rectal cancer
Cancer Research · 2026
Abstract 3587: Independent validation of polygenic risk scores for overall and triple-negative breast cancer among high-risk African American women.
Cancer Research · 2026
Experiences With Detection of Higher‐Copy Sex Chromosome Aneuploidy by cfDNA Screening: The Critical Role of Diagnostic Testing
American Journal of Medical Genetics Part A · 2026
Abstract PS2-09-07: Ultra-sensitive Molecular Residual Disease Detection in Breast Cancer Using Whole-Genome Sequencing-Based Personalized ctDNA Panels: Preliminary Results from the MONSTAR-SCREEN-3 Project
Clinical Cancer Research · 2026
Abstract PS3-02-30 : Ancestry-specific prevalence of pathogenic variants among patients with breast cancer who do not meet guidelines for genetic testing
Clinical Cancer Research · 2026
Abstract PS2-10-26: Tumor genomic profiling results in breast cancer patients: A comprehensive analysis from a laboratory research registry
Clinical Cancer Research · 2026
Abstract PS3-02-13: Enhancing breast cancer risk assessment in a community imaging center to identify high-risk patients and guide screening and management
Clinical Cancer Research · 2026
Abstract PS3-01-03: Interactions between polygenic variants and clinical factors as predictors of breast cancer risk in women of self-reported Black/African ancestry
Clinical Cancer Research · 2026
Simultaneous Prenatal cfDNA Screening of Aneuploidy, Recessive Single-Gene Conditions, and Fetomaternal Blood Compatibility
Clinical Chemistry · 2026
The Together Research
Performance Matters · 2025
Abstract PS4-02-02: Ultrasensitive ctDNA-based MRD monitoring predicts relapse in postoperative HR+ inflammatory breast cancer
Clinical Cancer Research · 2026